BridgeMD
New treatment option for Prurigo Nodularis
Official title Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis
ClinicalTrials.gov ID: NCT06779136
What this study is testing
- What it's testing
- A phase III clinical study to evaluate the efficacy and safety of a humanized MG-K10 mab injection in subjects with prurigo nodularis.administered every 4 weeks for 56 weeks.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- eligibility criteria:
- voluntarily sign the ICF and comply with all the visits and research-related procedures required by the protocol;
- Both men and women were required to be ≥ 18 and ≤ 80 years old at the time of signing the informed consent;
- the duration of PN diagnosed by a dermatologist at the time of screening was ≥ 3 months;
- In the range of 1-10, WI-NRS≥7 in the past 24 h at screening; WI-NRS in the week before the baseline visit The average weekly score was ≥ 7 points.
You likely can't join if
- There are skin diseases other than PN and mild atopic dermatitis (AD) that may interfere with the assessment of research outcomes.
- Patients who had a history of moderate to severe AD during the 6 months prior to the screening visit or screening visit.
- Receiving potent or super-potent TCS/TCI treatment within 2 weeks before or during screening. 4) Evidence of active tuberculosis. 5) Participation in...
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Bejing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Bejing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.